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Abstract
Background: The Ikka kinase, a subunit of the NF-kB-activating IKK complex, has emerged as an important regulator of
inflammatory gene expression. However, the role of Ikka-mediated phosphorylation in haematopoiesis and atherogenesis
remains unexplored. In this study, we investigated the effect of a bone marrow (BM)-specific activation-resistant Ikkamutant
knock-in on haematopoiesis and atherosclerosis in mice.
Methods and Results: Apolipoprotein E (Apoe)-deficient mice were transplanted with BM carrying an activation-resistant Ikka
gene (IkkaAA/AAApoe2/2) or with Ikka+/+Apoe2/2 BM as control and were fed a high-cholesterol diet for 8 or 13 weeks.
Interestingly, haematopoietic profiling by flow cytometry revealed a significant decrease in B-cells, regulatory T-cells and
effector memory T-cells in IkkaAA/AAApoe2/2 BM-chimeras, whereas the naive T-cell population was increased. Surprisingly,
no differences were observed in the size, stage or cellular composition of atherosclerotic lesions in the aorta and aortic root
of IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 BM-transplanted mice, as shown by histological and immunofluorescent stainings.
Necrotic core sizes, apoptosis, and intracellular lipid deposits in aortic root lesions were unaltered. In vitro, BM-derived
macrophages from IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 mice did not show significant differences in the uptake of oxidized
low-density lipoproteins (oxLDL), and, with the exception of Il-12, the secretion of inflammatory proteins in conditions of
Tnf-a or oxLDL stimulation was not significantly altered. Furthermore, serum levels of inflammatory proteins as measured
with a cytokine bead array were comparable.
Conclusion: Our data reveal an important and previously unrecognized role of haematopoietic Ikka kinase activation in the
homeostasis of B-cells and regulatory T-cells. However, transplantation of IkkaAA mutant BM did not affect atherosclerosis in
Apoe2/2 mice. This suggests that the diverse functions of Ikka in haematopoietic cells may counterbalance each other or
may not be strong enough to influence atherogenesis, and reveals that targeting haematopoietic Ikka kinase activity alone
does not represent a therapeutic approach.
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Introduction
Cardiovascular diseases are the main cause of morbidity and
mortality in western societies, with atherosclerosis being the
underlying pathology triggering most of the cardio- and cerebro-
vascular incidents. Atherosclerosis is a chronic inflammatory
disease of the vessel wall characterized by the activation of
endothelial cells, the subendothelial accumulation of oxidized low-
density lipoproteins (oxLDL) and the infiltration of inflammatory
cells such as neutrophils, monocytes, dendritic cells (DCs) and
lymphocytes [1,2].
A key regulator of inflammation and atherogenesis is the
transcription factor nuclear factor kB (NF-kB) [3]. The NF-kB
family has 5 members: p65 (RelA), c-Rel, RelB, NF-kB1 (p105,
processed to p50) and NF-kB2 (p100, processed to p52) [4]. Under
resting conditions, canonical NF-kB dimers (mostly p50/p65) are
predominantly found in the cytoplasm bound to the inhibitory of
kB (IkB)-a protein. Inflammatory signals such as TNF-a and
oxLDL activate the IkB kinase (IKK) complex, which consists of
two catalytically active kinases (IKKa/IKK1 and IKKb/IKK2)
and one regulatory component (IKKc/NEMO). The phosphor-
ylation of IkB-a by IKKb causes its ubiquitination and
proteasomal degradation. This releases the NF-kB dimer, allowing
a steady-state localization in the nucleus and the expression of
many pro-inflammatory proteins [5]. These pro-inflammatory
functions of canonical NF-kB activation have been linked to
atherogenesis in vivo, showing reduced lesion formation in
hyperlipidaemic Apolipoprotein E (Apoe)-deficient mice treated with
the NF-kB inhibitor DHMEQ, which prevents the TNF-a-
induced nuclear translocation of p65 [6]. Similarly, strongly
reduced atherosclerotic plaque formation was observed in Apoe2/2
mice with an endothelial cell-restricted inhibition of NF-kB
activation through endothelial Ikkc-deficiency or through an
endothelial cell-specific expression of a dominant-negative IkB-a
transgene [7]. On the other hand, NF-kB activity in leukocytes
also has an important role in the resolution of inflammation
through the transcription of anti-inflammatory cytokines such as
interleukin (IL)-10 [8] and the suppression of pro-inflammatory
IL1-b secretion [9]. Furthermore, an anti-inflammatory role was
described for IKKb by suppression of the classically activated (or
M1) macrophage phenotype [10]. These anti-inflammatory
properties of IKK/NF-kB signalling could explain the initially
unexpected increase in atherosclerosis in hyperlipidaemic Ldl
receptor (Ldlr)-deficient mice with a myeloid-specific deletion of Ikkb,
which was linked to a significant reduction of the anti-inflamma-
tory cytokine IL-10 in Ikkb2/2 macrophages [11]. Thus, IKKb/
NF-kB signalling plays a complex role in inflammation and
atherogenesis by driving both pro- and anti-inflammatory
processes, and the outcome of NF-kB inhibition on atherosclerosis
seems strongly dependent on the targeted cell type.
In contrast to IKKb and IKKc, the role of IKKa in
atherogenesis has not been investigated. Although IKKa is not
required for canonical IkB-a phosphorylation and subsequent NF-
kB activation [12,13], the IKKa kinase exerts multiple NF-kB-
dependent and -independent functions that could potentially
influence atherogenesis [4,14]. First, IKKa homodimers mediate
alternative NF-kB activation through phosphorylation of NF-kB
p100, triggering p100 processing and the release and nuclear
localization of RelB-p52 dimers [4,15]. This pathway, induced by
several members of the TNF-superfamily as BAFF and CD40
ligand, plays a central role in B-cell maturation and lymphoid
organ formation and may thus implicate IKKa in atherogenesis
through the recently appreciated role of B-cells in this pathology
[16]. Secondly, nuclear IKKa modulates gene expression through
phosphorylation of histone H3, mediating the expression of a
subset of canonical NF-kB-dependent genes in TNF-a-stimulated
mouse embryonic fibroblasts [17,18]. On the other hand, IKKa
has also been associated with repression or termination of gene
transcription. For example, an anti-inflammatory role has been
described for IKKa kinase in macrophages by inducing the
phosphorylation, promoter removal and degradation of the
canonical NF-kB isoforms p65 and c-Rel [19]. Furthermore,
diverse pro-inflammatory stimuli trigger the IKKa-mediated
phosphorylation of the transcriptional repressor PIAS1, which
then negatively regulates the expression of a predominantly pro-
inflammatory subset of p65- and STAT1-dependent genes [20]. In
addition, IKKa-mediated phosphorylation of TAX1BP1 triggers
the assembly of the A20 ubiquitin-editing complex, which is an
important negative regulator of canonical NF-kB activation [21].
In conclusion, the IKKa kinase can positively or negatively
regulate cell signalling and pro- and anti-inflammatory gene
expression by phosphorylating diverse substrates, and could thus
play a complex role in atherogenesis as well.
As haematopoietic cells are crucial players in the inflammatory
reactions driving atherosclerosis, this study investigated the role of
haematopoietic IKKa kinase activation in haematopoiesis and
atherogenesis after transplantation of atherosclerosis-prone Apoe2/2
mice with bone marrow carrying an activation-resistant IkkaAA/AA
mutant [22].
Materials and Methods
Nomenclature
The letter format of all gene and protein notations in this
manuscript is in accordance with internationally agreed gene/
protein nomenclature guidelines: all letters of human genes/
proteins are in uppercase, whereas for mouse genes/proteins, only
the first letter is in uppercase. Gene names are in italics.
Mouse model, bone marrow (BM) transplantation and
ethics statement
C57BL/6 IkkaAA/AA mice, which are homozygous for an
activation-resistant mutant of Ikka through replacement of the
serines 176/180 in the kinase activation loop with alanines [22],
were crossed with atherosclerosis-prone C57BL/6 Apoe2/2 to
generate IkkaAA/AA Apoe2/2 mice. BM cells (36106/mouse) from
IkkaAA/AAApoe2/2 mice or from Ikka+/+Apoe2/2 littermate controls
were flushed from femur and tibia marrow cavities and were
subsequently administered to female C57BL/6 Apoe2/2 recipient
mice by lateral tail vein injection one day after a lethal dose of
whole-body irradiation (266.5 Gy). After four weeks of recovery,
the mice were put on a high-fat diet containing 21% fat and 0.15%
cholesterol (Altromin) for either 8 or 13 weeks, as indicated. All
animal experiments were approved by local authorities (Land-
esamt fu¨r Natur, Umwelt und Verbraucherschutz Nordrhein-
Westfalen, Germany; approval number 8.87-50.10.35.08.073) and
complied with the German animal protection law. All surgery was
performed under ketamine/xylazin anesthesia, and all efforts were
made to minimize suffering.
Determination of chimerism
The degree of chimerism in BM-transplanted mice was
determined by quantifying the mutated IkkaAA allele relative to
the wild-type Ikka allele in genomic DNA isolated from blood cells.
Real-time quantitative PCR analysis was performed using the
Maxima SYBR Green qPCR Mastermix (Fermentas) in a thermal
cycler 7900HT (Applied Biosystems) using specific primer pairs
(Sigma-Aldrich): 59-CCTCTCAGTGGCTCACCTTT and 59-
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CAATGTTCCCACAAAAGATGTACAGAGACT (for Ikka); 59-
CCTCTCAGTGGCTCACCTTT and 59-CAATGTTCCCA-
CAAACGCTGTACAGAGCGC (for IkkaAA); 59-CAAC-
GAGCGGTTCCGATG and 59-GCCACAGGATTCCATACC-
CAA (for b-Actin). b-Actin was used as a reference gene. The
method was validated by analyzing a standard curve using
genomic DNA from IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 blood
cells, mixed at different ratios.
Lipid measurement in blood serum
Cholesterol and triglyceride levels in the blood serum were
quantified using enzymatic assays (Cobas, Roche) according to the
manufacturer’s protocol. High-density (HDL), low-density (LDL)
and very low-density (VLDL) cholesterol profiles were determined
after HPLC-based fractionation of pooled serum samples using a
Superose 10/300GL column followed by in-line cholesterol
detection as described by Parini et al. [23].
Haematopoietic profiling and serum cytokine
quantification
Lymph nodes, spleen, thymus and BM were harvested and a
single-cell suspension was prepared and filtered over a 70 mm cell
strainer (Greiner). Splenocytes, BM cells and EDTA-buffered
blood, obtained by retro-orbital puncture, were treated with
erythrocyte lysis buffer (0.155 M NH4Cl, 10 mM NaHCO3) at
room temperature. All cell suspensions were washed with HANKS
Complete buffer containing 16HBSS with 0.3 mM EDTA and
0.1% BSA, and stained with combinations of antibodies to Cd45,
Cd11b, MhcII, Cd19, Cd3, Cd62L or Cd25 (BD Bioscience), to
Cd11b, Cd115, Gr1, Cd3, Cd4, Cd8a, Cd25, Foxp3, Cd44,
Cd11c or 440c (eBioscience), or to B220 (BioLegend). Intracellular
labelling of Foxp3 was performed using the mouse regulatory T-
cell staining kit (eBioscience) according to the manufacturer’s
protocol. Flow cytometric analysis was performed using a
FACSCanto II and FACSDiva software (BD Biosciences) after
appropriate fluorescence compensation, and leukocyte subsets
were gated using FlowJo software (Treestar). B-cells were identified
as Cd45+Cd19+ or B220+ as indicated; T-cells as Cd45+Cd3+;
naive T-cells as Cd44lowCd62Lhigh T-cells; effector memory T-
cells as Cd44highCd62Llow T-cells; central memory T-cells as
Cd44highCd62Lhigh T-cells; regulatory T-cells (Treg cells) as
Cd4+Cd25+Foxp3+ T-cells; neutrophils as Cd45+Cd1152Gr1high;
monocytes as Cd45+Cd115+; conventional DCs (cDCs) as
Cd45+Cd11c+MhcII+; and plasmacytoid DCs (pDCs) as
Cd45+Cd11c+Cd11b2440c+.
Cytokine levels in the blood serum were measured by flow
cytometry using the BD Cytometric Bead Array Mouse Inflam-
mation Kit (for Tnf-a, Mcp1, Il6, Ifn-c, Il12 and Il10; BD-
Pharmingen). In addition, Il10 levels were measured using a
mouse Il10 Quantikine ELISA kit (R&D Systems).
Atherosclerotic lesion analysis using histology and
immunofluorescence staining
For atherosclerotic lesion analysis, the aortic root and thoraco-
abdominal aorta were stained for lipid depositions with Oil-Red-
O. In brief, the heart with aortic root was embedded in Tissue-Tek
for cryo sectioning. Atherosclerotic lesions were quantified in 5 mm
transverse sections and averages were calculated from 3–5
sections. The aorta was opened longitudinally, mounted on glass
slides and en face-stained. Macrophages, smooth muscle cells
(SMCs) and T-cells in the atherosclerotic lesions were visualized by
immunofluorescent staining for Mac2 (Cedarlane), Sma (Dako)
and Cd3 (AbD Serotec), respectively, followed by a FITC- or Cy3-
conjugated secondary antibody staining (Jackson ImmunoRe-
search). Appropriate IgG antibodies were used as isotype controls.
Nuclei were counterstained by 49,6-diamidino-2-phenylindol
(DAPI). Neutrophil presence was examined by Naphthol-AS-D-
chloroacetate Esterase (ASDCL) staining. Apoptotic nuclei were
detected by terminal deoxynucleotidyl nick-end labelling (TU-
NEL-kit, Roche). Intracellular lipid deposits in aortic root lesions
were stained using Nile Red (N-3013, Sigma). All images were
recorded with a Leica DMLB fluorescence microscope and CCD
camera. The quantification of lesion size and composition was
performed using Diskus analysis software (Hilgers), whereas the
Nile Red stainings were analyzed with help of Image J software.
All analyses were performed without prior knowledge of the
genotype.
To explore potential qualitative effects on atherosclerosis, the
aortic root lesions were classified according to phenotype, as
previously described [11]. Three categories were distinguished: (1)
early lesions, containing only foam cells, (2) intermediate-type
lesions, presenting foam cells, some necrosis and a fibrotic cap, (3)
advanced lesions, showing extended fibrosis and necrosis and
infiltration of the plaque into the media.
Preparation and labelling of oxLDL
OxLDL was prepared by oxidation of LDL (Calbiochem) with a
50 nM copper sulphate solution for 4 hours at 37uC for mildly
oxidized LDL and overnight for heavily oxidized LDL, followed
by purification over a PD 10 column (GE Healthcare). For lipid
uptake experiments heavily oxidized LDL was labelled with 1,10-
dioctadecyl-3,3,3030-tetramethylindocyanide percholorate (Dil).
After incubation of 0,5 mg/ml oxLDL with 20 mL of Dil (stock
3 mg/ml in DMSO) overnight at 37uC, the Dil-labelled oxLDL
was purified over a PD 10 column and stored at 4uC for a
maximum of 2 weeks.
BM-derived macrophages, nuclear extracts and NF-kB
p65 DNA-binding ELISA
BM-derived macrophages were generated as previously de-
scribed [24]. Briefly, BM from the femurs and tibiae was flushed
with ice-cold PBS using a 27-G needle, resuspended in PBS by
repeated vigorous pipetting and filtered using a 70 mM cell strainer
(BD Biosciences). The filtered solution was centrifuged, the
resulting pellet resuspended in culture medium and the cells
plated on 15 cm untreated culture dishes (Greiner). BM-derived
macrophages from cryopreserved BM-cells were generated as
previously described [25]. Culturing and stimulation of BM-
derived macrophages were performed in RPMI 1640 (+L-
Glutamin) containing 10 mM Hepes, 10% FCS, 15% L929-cell-
conditioned medium and 100 U/ml gentamycin. After 7 days of
culturing, differentiated macrophages were used for stimulation
experiments and transferred onto untreated 6-well dishes (Grei-
ner). The cells were left for 24 hours to adhere und were then
stimulated with 100 ng/ml lipopolysaccharide (LPS) (Sigma-
Aldrich), 10 ng/ml mouse Tnf-a (Peprotech) or 50 mg/ml mildly
oxidized LDL, as indicated.
Nuclear extracts were isolated as described [11]. Briefly, BM-
derived macrophages were washed once with PBS and scraped of
the culture dish using PBS with 5 mM EDTA. The cells were
centrifuged and the cell pellet was resuspended in 100 ml buffer A
(10 mM Hepes pH 7.8, 1.5 mM MgCl2, 0.5 mM DTT and 16
Complete EDTA-free protease inhibitor cocktail (Roche)). After
2 min incubation on ice, 100 ml of buffer A supplemented with
1.28% NP40 was added to the cell suspension and incubated on
ice for 10 min. The cells were vortexed for 10 sec and centrifuged
for 10 min at 2000 rpm. The supernatant was removed, the pellet
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dissolved in 50 ml buffer B (20 mM Hepes pH 7.8, 420 mM NaCl;
1,2 mM MgCl2, 0.2 mM EDTA, 25% glycerol, 0.5 mM DTT
and 16Complete EDTA-free protease inhibitor cocktail (Roche))
and incubated for 30 min on ice. Every 5 min, the sample was
vortexed thoroughly. Then the solution was centrifuged for
15 min at 4000 rpm and the supernatant, being the nuclear
lysate, was snap-frozen at 280uC. Protein concentration was
determined using the Quick Start Bradford Protein Assay (Biorad).
NF-kB p65 DNA-binding activity in equal amounts of nuclear
extracts was quantified using an oligonucleotide-based ELISA
(TransAM NF-kB p65 ELISA, Active Motif) according to the
supplier’s instructions. Absorbance values were corrected for
background by incubation with lysis buffer only.
In vitro macrophage foam cell formation and cytokine
secretion
To quantify the uptake of DiI-labelled heavily oxidized LDL by
BM-derived macrophages, macrophages were plated on 24-well
plates and incubated overnight at 37uC. The next day, non-
adherent cells were rinsed off with PBS and medium containing
1 mg/ml or 10 mg/ml Dil-oxLDL was added. To analyze whether
oxLDL uptake occurred in an actin-dependent way, controls were
pre-incubated for 1 h with 10 mM cytochalasin D, followed by a
stimulation with 10 mg/ml Dil-oxLDL and 10 mM cytochalasin
D. The cells were stimulated for 3 or 24 hours as indicated,
washed with PBS and stained with F4/80 (clone BM8,
eBioscience). Flow cytometric analysis was performed using a
FACSCanto II and the data were analyzed using FlowJo software
(Treestar). Data were calculated by subtracting the cell autofluo-
rescence (cells without diI-oxLDL incubation) from the fluores-
cence of the diI-oxLDL-treated samples and were expressed as
geometric mean fluorescence intensity (gMFI).
To measure cytokine and chemokine secretion from BM-
derived macrophages, cells were plated in 6-well plates, left for
24 h to adhere und were then stimulated with 10 ng/ml mouse
Tnf-a (Peprotech) or 50 mg/ml heavily oxidized LDL. As control
unstimulated cells were included. After 24 h the medium was
harvested from the cells, and cytokine and chemokine levels were
measured by flow cytometry using the BD Cytometric Bead Array
Mouse Inflammation Kit (BD-Pharmingen). In addition, Mcp1
levels were measured using a mouse Mcp1 ELISA (DY479, R&D
Systems).
Statistical analysis
All statistical analyses were performed using GraphPad Prism
(GraphPad Software Inc.). Data are represented as means 6 SEM
and were analyzed by 2-tailed Student’s t-test or 2-way ANOVA
with Bonferroni post-test, as appropriate. P,0.05 was considered
statistically significant.
Results
Bone marrow-specific loss of Ikka kinase activation
affects B- and T-lymphocyte populations
To study the role of IKKa kinase activation in haematopoiesis
in the context of atherosclerosis, BM was isolated from Ikka+/
+Apoe2/2 or IkkaAA/AAApoe2/2 mice, the latter carrying an non-
activatable mutant of Ikka through replacement of serines 176/
180 in its activation loop with alanine residues [22]. After
transplantation of this BM into lethally irradiated Apoe2/2 mice
and a recovery period of four weeks, the mice received a high-
cholesterol diet for 13 weeks to accelerate atherosclerosis.
Quantitative real-time PCR for the IkkaAA/AA vs Ikka+/+ allele in
white blood cells of the transplanted recipient mice indicated that
on average 96.1% (61.2) of leukocytes carried the mutant IkkaAA/AA
allele, confirming a successful engraftment.
Interestingly, although total leukocyte counts were unaffected,
IkkaAA/AAApoe2/2 BM chimeras showed a significantly reduced
Cd19+ B-cell population in peripheral blood (Figure 1A, Table 1).
A similar decrease in B-cell number was seen in the BM and
lymph nodes of the IkkaAA/AAApoe2/2 BM chimeras, whereas no
difference was observed in the spleen B-cell population (Figure S1).
In addition, also Cd3+Cd4+Cd25+Foxp3+ regulatory T-cells
(Treg), which are associated with atheroprotection [26], were found
to be significantly reduced in the Cd3+ T-cell population of the
peripheral blood, thymus and secondary lymphoid organs of the
IkkaAA/AAApoe2/2 -transplanted mice (Figure 1B). Also among
Cd45+ leukocytes, Treg frequency was markedly decreased in
blood and spleens of the IkkaAA/AAApoe2/2 BM chimeras
(Figure 1B). However, this was not observed in the lymph nodes
(Figure 1B), which showed a significant overall increase of Cd3+ T-
cells in the leukocyte population (Figure S1B).
No changes were observed in the relative proportions of Cd4+
and Cd8a+ T-cell subsets in blood or lymphoid organs (Figure 1A,
Figure S1). However, spleen and lymph nodes of IkkaAA/AAApoe2/2-
transplanted mice displayed a significant increase in the
Cd3+Cd44lowCd62Lhigh naive T-cell population, whereas
Cd3+Cd44highCd62Llow effector memory T-cells, which mediate
effector functions in inflamed tissue [27], were significantly reduced
(Figure 1C, Figure S2). Also, the Cd3+Cd44highCd62Lhigh central
memory T-cell population, associated with the successive produc-
tion of effector T-cells [27], was significantly decreased among
splenic T-lymphocytes and total leukocytes (Figure S3).
Furthermore, relative frequencies of Cd1152Gr1+ neutrophils,
Cd115+ monocytes and both Gr1high and Gr1low monocyte subsets
in the peripheral blood were unchanged (Table 1). Also,
splenocytes showed comparable frequencies of Cd11c+MhcII+
conventional dendritic cells (cDCs) and Cd11c+Cd11b2440c+
plasmacytoid DCs (pDCs) (Figure 1D). Nonetheless, expression of
the activation marker MhcII was significantly reduced on splenic
pDCs of IkkaAA/AAApoe2/2 BM chimeras (Figure 1D).
A similar effect on B- and T-cell populations was observed in a
non-atherosclerotic context. C57BL/6 mice transplanted with
IkkaAA/AA BM displayed a significantly reduced B-cell population
in lymph nodes compared to controls, whereas both Cd4+ and
Cd8a+ T-cell subsets were increased (Figure S4A,B). Similarly as
observed before, Treg lymphocytes were markedly decreased
(Figure S5). Altogether, these findings indicate an important role
for Ikka kinase activity in haematopoiesis, with reduced B-cells
and Treg lymphocytes upon haematopoietic expression of an
IkkaAA/AA mutant.
Atherosclerotic lesions are unaltered in IkkaAA/AAApoe2/2
bone marrow chimeras
After 13 weeks of high-cholesterol diet, IkkaAA/AAApoe2/2 and
Ikka+/+Apoe2/2 BM chimeras were sacrificed and lipid levels in
serum and the extent of atherosclerosis in the aorta and aortic root
were analyzed. Whereas body weight and serum triglyceride
values were similar, cholesterol levels were significantly increased
in IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 BM-transplanted Apoe2/2
mice (Figure 2A,B). This could be attributed to an increase in
VLDL and LDL lipoprotein fractions, as shown by a cholesterol
analysis after HPLC-based lipoprotein size separation of pooled
serum samples (Figure 2C). Despite these differences in cholesterol
levels, atherosclerotic lesion sizes in the aorta and aortic root were
comparable in IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM chime-
ras (Figure 2D,E). To explore potential qualitative effects on
atherosclerosis, the aortic root lesions were phenotypically
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classified into early, intermediate-type and advanced lesions, as
previously described [11]. Again, no differences were found
between both groups (Figure 2F). Also, the cellular composition of
aortic root lesions was comparable, presenting an equal content of
macrophages (Mac2+) and SMCs (Sma+) as shown by immuno-
fluorescent stainings (Figure 3A,B). Similarly, no significant
differences were observed in lesional Cd3+ T-lymphocyte content
(Figure 3C). No neutrophils could be detected in any of the aortic
root lesions. Finally, necrotic core sizes were comparable
(Figure 4A), and no significant differences were found in the
content of TUNEL+ apoptotic cells and apoptotic macrophages in
aortic root lesions of IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM
chimeras (Figure 4B,C).
Figure 1. IkkaAA/AAApoe2/2 BM-chimeras have less B-cells, Treg and effector memory T-cells, and more naive T-cells. Shown is flow
cytometric analysis of peripheral blood, thymus and secondary lymphoid organs of Apoe2/2 mice transplanted with IkkaAA/AAApoe2/2 or Ikka+/
+Apoe2/2 BM and receiving a high-cholesterol diet for 13 weeks. (A) Cd19+ B-cell and Cd3+ T-cell populations as percentage of Cd45+ leukocytes, and
Cd4+ and Cd8a+ T-cell subsets as percentage of Cd3+ T-cells in peripheral blood. (B) Cd3+Cd4+Cd25+Foxp3+ regulatory T-cell (Treg) levels as
percentage of Cd3+ T-cells and Cd45+ leukocytes. (C) Cd3+Cd44lowCd62Lhigh naive T-cells and Cd3+Cd44highCd62Llow effector memory T-cells as
percentage of Cd3+ T-cells and Cd45+ leukocytes. Left Y-axes belong to naive T-cells, right Y-axes to effector memory T-cells. (D) Cd11c+MhcII+
conventional dendritic cells (cDCs) and Cd11c+Cd11b2440c+ plasmacytoid DCs (pDCs) as percentage of Cd45+ leukocytes (left). Surface expression of
MhcII on splenic cDCs and pDCs (right). (A–D) All graphs represent the mean 6 SEM (n= 18–19); 2-tailed t-test, *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0087452.g001
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To investigate potential effects on earlier stages of atheroscle-
rosis, a similar study was performed after a high-cholesterol diet
fed for only 8 weeks. Successful engraftment of IkkaAA/AAApoe2/2
BM into lethally irradiated Apoe2/2 mice was again confirmed by
quantitative real-time PCR, showing the mutant IkkaAA/AA allele to
be present in 94.3% (62.7) of blood leukocytes. After this shorter
period of high-fat diet, no differences were obtained in body
weight or lipid levels in the blood serum, and also HPLC-based
lipoprotein fractionation of pooled serum samples showed
comparable HDL-, LDL- and VLDL-associated cholesterol peaks
(Figure 5A–C). Similarly as for the 13 week-high-fat diet, IkkaAA/
AAApoe2/2 and Ikka+/+Apoe2/2 BM chimeras presented compara-
ble atherosclerotic lesion sizes in the aorta and aortic root
(Figure 5D,E). Lesions were reduced in size with 39% and 56% in
aorta and aortic root, respectively, compared to the longer diet
course, as can be expected. Also, classification of the plaques into
early, intermediate or advanced stages revealed comparable lesion
phenotypes in IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM-trans-
planted Apoe2/2 mice, although the lesions were less advanced
compared to the 13 week-diet study (Figure 5F).
In summary, these data indicated that the transplantation of
IkkaAA/AAApoe2/2 -mutant BM does not affect the size, phenotype
or cellular content of atherosclerotic lesions in atherosclerosis-
prone Apoe2/2 mice.
Haematopoietic knock-in of the IkkaAA/AA mutant does
not affect systemic inflammatory gene expression in
ApoE-deficient mice
The canonical NF-kB pathway has been shown to play an
important role in controlling atheroprogression, at least partly by
balancing anti- and pro-inflammatory processes in macrophages
[11]. Canonical NF-kB activation is dependent on IKKb and
IKKc, but does not require IKKa kinase activity for IKK-
mediated IkB-a phosphorylation and degradation with subsequent
NF-kB activation [12,13]. On the other hand, IKKa has been
shown to terminate LPS-induced NF-kB activity in macrophages
by promoting the phosphorylation and degradation of the NF-kB
isoform p65, thereby abrogating p65-mediated gene transcription
[19]. Therefore, we aimed to examine the direct effect of the
IkkaAA/AA knock-in mutation on canonical NF-kB activity in the
context of atherosclerosis by studying the DNA binding capacity of
p65 in nuclear extracts of IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2
BM-derived macrophages in vitro. Unexpectedly, the IkkaAA/AA
knock-in mutation did not enhance or prolong p65 activity in Apoe-
deficient macrophages upon stimulation with Tnf-a or oxidized
LDL (oxLDL), i.e. mimicking inflammatory or atherogenic
challenges, and even slowed down Tnf-a-induced p65 activation.
No differences were observed in LPS-induced p65 activity in
IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 BM-derived macrophages
(Figure 6A).
Furthermore, the concentrations of the inflammatory proteins
Tnf-a, Il-6 and Mcp1 in supernatants of Tnf-a- or oxLDL-
stimulated IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM-derived
macrophages were not significantly different, although IkkaAA/AA
knock-in significantly enhanced the basal secretion of Mcp1, in
contrast to Tnf-a or Il-6 (Figure 6B). Neither Tnf-a nor oxLDL
were able to induce secretion of Il-10 or Il-12p70 in vitro, although
Il-12p70 secretion was found to be significantly higher in oxLDL-
stimulated macrophages upon IkkaAA/AA knock-in (Figure S6). In
addition, quantification of Tnf-a, Il-6 and Mcp1 in serum of
IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 BM chimeras after 8 weeks of
high-fat diet did not reveal significant differences (Figure 6C),
whereas the cytokines Ifn-c, Il-12 and Il-10 remained below the
detection limit in both groups.
Given the importance of lipid uptake by macrophages in
atherosclerotic lesions, we examined a possible effect of IkkaAA/AA
knock-in on macrophage foam cell formation in vitro. With 2
different incubation times and oxLDL doses, we did not observe a
significant difference in oxLDL uptake by IkkaAA/AAApoe2/2 vs
Ikka+/+Apoe2/2 BM-derived macrophages (Figure 7A). Cytocha-
lasin D severely reduced the oxLDL-associated fluorescence signal,
indicating that oxLDL was actively taken up by the cells in an
actin-dependent way and not merely binding the cell surface
(Figure 7A). Next, we quantified lipid deposits in aortic root lesions
of IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM chimeras after 13
weeks of high-cholesterol diet using Nile Red staining, but no
difference were observed (Figure 7B,D). Also, quantification of
Nile Red-positive macrophages after co-staining for Mac2 together
with Nile Red dye revealed comparable intracellular lipid deposits
in lesional macrophages and an equal amount of lipid-laden
macrophages (Figure 7C,D).
In conclusion, these data show that knock-in of IkkaAA/AA in an
Apoe2/2 background does not enhance NF-kB activity or majorly
influence the secretion of important inflammatory proteins from
Tnf-a- or oxLDL-stimulated macrophages, nor does it significantly
affect macrophage foam cell formation.
Discussion
Atherosclerosis is characterized by a chronic inflammation of
the vessel wall and all leukocyte subsets, including B- and T-
lymphocytes, monocytes and monocyte-derived macrophages,
neutrophils and DCs, contribute in their own specific ways to
the pathogenesis of this widespread disease [1,2]. Therefore, we
investigated the effect of a BM-specific non-activatable IkkaAA
knock-in on haematopoiesis in conditions of atherosclerosis and
identified a significant reduction in the B-cell population in the
blood and lymph nodes of hyperlipidaemic IkkaAA/AAApoe2/2 BM
chimeras in comparison with Ikka+/+Apoe2/2 BM-transplanted
Apoe2/2 controls (Figure 1A, Figure S1). Comparable results were
obtained in a non-atherosclerotic context, with a significantly
reduced B-cell population in lymph nodes of C57BL/6 mice
transplanted with IkkaAA/AA vs Ikka+/+ BM (Figure S4), and are
consistent with earlier observations of a reduced mature B-cell
population in secondary lymphoid organs of IkkaAA/AA knock-in
mice and in Ikka2/2 and IkkaAA/AA BM chimeras [15,28]. Similar
effects were seen in Baff2/2 mice [29] and revealed a crucial role
Table 1. Leukocyte numbers and frequencies of leukocyte
subsets in Apoe2/2 mice transplanted with IkkaAA/AAApoe2/2
or Ikka+/+Apoe2/2 BM.
Ikka+/+Apoe2/2
BM
IkkaAA/AAApoe2/2
BM
Leukocytes (6103/ml blood) 7.960.6 7.160.3
Monocytes (% of leukocytes) 7.960.5 8.760.6
Gr1high monocytes (% of monocytes) 66.062.0 68.162.7
Gr1high monocytes (% of leukocytes) 5.260.3 5.760.3
Gr1low monocytes (% of monocytes) 29.862.1 26.962.4
Gr1low monocytes (% of leukocytes) 2.460.3 2.560.3
Neutrophils (% of leukocytes) 19.061.3 20.461.2
Peripheral blood leukocyte counts were determined after 8 weeks of high-fat
diet (n = 8). Leukocyte subset frequencies were quantified by flow cytometry
after 13 weeks of high-fat diet (n = 18–19).
doi:10.1371/journal.pone.0087452.t001
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for the non-canonical Baff-Baffr-Nik-Ikka pathway in B-cell
maturation and survival. Our observation that the Cd19+ B-cell
population is also significantly decreased in the BM of IkkaAA/
AAApoe2/2-transplanted Apoe2/2 mice (Figure S1) suggests that the
Ikka kinase activity is also important in BM B-cell development.
This corresponds to recent findings of Balkhi and colleagues, who
identified a reduction in the Cd19+, B220+ and Cd19+B220+ B-cell
population in the BM of kinase-dead Ikka (IkkaKA/KA) knock-in
mice and IkkaKA/KA BM chimeras, and also revealed less
B220+Cd19+ B-cells in the BM of irradiated Rag2/2 mice
reconstituted with Ikka2/2 fetal liver cells [30]. Thus, our data
support this important role for Ikka kinase activity in early B-cell
Figure 2. Knock-in of IkkaAA/AA in haematopoietic cells does not influence advanced atherosclerosis in Apoe2/2 mice. Apoe2/2 mice
were transplanted with IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM and received a high-cholesterol diet for 13 weeks before analysis. (A,B) Body weight
(A) and lipid analysis in blood serum (B) (n = 18). (C) Cholesterol levels after HPLC-based size fractionation of pooled blood serum samples. (D,E)
Atherosclerotic lesion sizes in the aorta (D) and aortic root (E) (n = 16–19). Representative pictures of Oil-Red-O+ lipid depositions in aorta and aortic
root are shown. Scale bar = 500 mm. (F) Classification of aortic root lesions according to their severity. Shown is the plaque distribution as percentage
of the total number of lesions examined (n = 18–27). (A,B,D,E) Graphs represent the mean 6 SEM; 2-tailed t-test, ***P,0.001.
doi:10.1371/journal.pone.0087452.g002
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development in the BM, which was revealed to involve both
canonical and non-canonical NF-kB pathways [30].
Secondly, we observed a consistent increase in the Cd62LhighC-
d44low naive T-cell population in secondary lymphoid organs of
IkkaAA/AAApoe2/2 BM chimeras, whereas Cd62LlowCd44high
effector memory T-cells were decreased (Figure 1C). This
corresponds with a previous observation of Mancino and
colleagues, who revealed that Ikka kinase activity in DCs is
crucial for antigen-specific priming of naive T-cells in an in vivo
delayed-type hypersensitivity model [31]. Similar effects on the
ratio of naive vs effector memory T-cells were seen in mice
deficient for Nik, the kinase activating Ikka in the non-canonical
NF-kB pathway [32]. Likewise, Nikaly/aly mice, which carry a
natural Nik mutant (Nikaly) unable to bind Ikka and associated with
reduced NF-kB activation [33–35], presented with reduced T-cell
effector cytokine expression, which was ascribed to a Nik-
deficiency in thymic DCs rather than to an intrinsic T-cell defect
[36]. Despite equal DC numbers in the thymus of Nikaly/aly and
Nik+/+ mice, thymic Nikaly/aly DCs showed a decreased expression
of typical activation markers [36]. Similarly, also splenic Nikaly/aly
DCs expressed a considerably lower level of MhcII compared to
Nikaly/+ DCs [37], suggesting an inability of Nikaly/aly DCs to deliver
T-cell costimulatory signals and contribute to the development of
effector T-cells [36]. In line with this, our IkkaAA/AAApoe2/2 BM
chimeras displayed a significantly reduced MhcII expression on
splenic pDCs (Figure 1D). Very recently, an increased ratio of
naive vs effector memory T-cells was also seen in Nik2/2 BM
chimeras, but was linked with a cell-intrinsic role of Nik in the
generation or maintenance of effector memory T-cells [38]. Given
these new findings together with the previous observations of
Figure 3. Knock-in of IkkaAA/AA in haematopoietic cells does not influence the cellular composition of atherosclerotic lesions.
Immunofluorescent stainings of aortic roots from Apoe2/2 mice reconstituted with IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM and receiving a high-fat
diet for 13 weeks. (A–C) Quantification of Mac2+ macrophages (A, n = 17–18), Sma+ SMCs (B, n = 16–17) and Cd3+ T-cells (C, n = 7–8) as percentage of
all plaque cells (left) and relative to the plaque area (right). Graphs represent the mean6 SEM. Representative pictures are shown. Scale bar = 100 mm.
doi:10.1371/journal.pone.0087452.g003
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Mancino et al. [31], the relative importance of cell-intrinsic vs DC-
mediated effects on the increased ratio of naive vs effector memory
T-cells in our IkkaAA/AA BM chimeras remains to be investigated.
In addition to reduced effector memory T-cells, IkkaAA/
AA(Apoe2/2) BM chimeras displayed a significantly reduced Treg
population (Figure 1B, Figure S5). Treg cells develop in the thymus
and in peripheral sites from naive CD4+ T-cells. Initially, defective
alternative NF-kB activation in the thymic stroma and a
disorganized thymic structure in Nikaly/aly mice was associated
with a defective establishment of self-tolerance and reduced Treg
numbers [39]. Later, a study of single Nik2/2 vs mixed Nik2/2/
Nik+/+ BM chimeras indicated an additional cell-intrinsic role for
Nik in the maintenance of peripheral Treg T-cells [38]. Also, at
least part of the Treg defect in Nik
aly/aly mice was attributed to the
reduced capacity of Nikaly/aly DCs to trigger Treg expansion and
survival in vitro [37], and both NIK and IKKa were shown to be
required in human DCs to trigger the development of Treg cells
from naive CD4+ T-cells in vitro [40]. Subsequently, pDC-triggered
Treg development from naive T-cells was associated with the
induction of indoleamine 2,3-dioxygenase in pDCs by NIK-
mediated non-canonical NF-kB activation [40–43]. With Ikka a
crucial player in this alternative NF-kB pathway, our data now
directly confirm for the first time a role for haematopoietic Ikka
kinase activation in the generation of Treg cells in vivo. However,
the relative importance of Treg-intrinsic vs DC-mediated mecha-
nisms remain to be investigated, both in the periphery as thymus,
given that peripheral DCs can migrate into the thymus to actively
contribute to thymic Treg generation [44]. Of note, the reduced
Treg population in Ikka
AA/AAApoe2/2 BM chimeras could be
associated with the increased serum levels of VLDL observed in
these mice, as depletion of Treg T-cells was recently discovered to
enhance VLDL levels through reduced VLDL clearance [45].
Despite the clear effects of a BM-specific IkkaAA/AAApoe2/2
knock-in on haematopoiesis and the enhanced VLDL levels, no
differences were observed in the size, phenotype and cellular
composition of atherosclerotic lesions in hyperlipidaemic Apoe2/2
mice transplanted with IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM
(Figure 2–5). The influence of the reduced B-cell population in the
IkkaAA/AAApoe2/2 BM chimeras on atherosclerosis is unclear. On
the one hand, an atheroprogressive effect could be suggested based
on the observation that a transplantation of Ldlr2/2 mice with B-
cell deficient (mMT) BM aggravated atherosclerosis [46] and also
several other studies indicated an atheroprotective role for B-cells
[1,16]. However, different B-cell subsets have diverse functions in
atherogenesis and B2 B-cells, in contrast to B1 B-cells, rather
exacerbate atherosclerosis [16]. In this context, a lack of B2 B-
cells, but a preserved B1 B-cell population was detected in mice
with a deficiency of Baff [29] or Baffr [47], which can signal to NF-
kB through Ikka. This was associated with reduced atherosclerosis
in Baffr2/2Apoe2/2 or Baffr2/2 BM-transplanted Ldlr2/2 mice
compared to controls [48,49]. Although B-cell subsets were not
examined in our study, Senftleben et al. predominantly found a
reduction in the mature IgMlowIgDhigh B-cell population in IkkaAA/
AA mice and IkkaAA/AA BM chimeras [15], with IgD being a surface
marker of follicular B2 B-cells [16]. Thus, the reduced B-cell
population in our IkkaAA/AAApoe2/2 BM chimeras may by itself
provide atheroprotective effects through a potential decrease in B2
B-cells. Regarding T-lymphocytes, effector memory T-cells are
present in atherosclerotic lesions [1] and were shown to positively
correlate with the extent of atherosclerosis in atherogenic mice,
whereas naive T-cells were inversely correlated with plaque size
[50]. Furthermore, Treg T-cells have been shown to mediate
atheroprotective functions [1,26]. Therefore, pro-atherogenic
effects of a reduction in the Treg population in Ikka
AA/AAApoe2/2
BM chimeras may be compensated by atheroprotective effects of
the observed relative increase of naive versus effector memory T-
cells in these mice. Comparable results were seen upon deficiency
of Cd40-Traf2/3/5 signalling in Apoe2/2 mice, which did not
affect atherosclerosis despite an increase in both atheroprogressive
effector memory T-cells and atheroprotective Treg cells in blood
and secondary lymphoid organs [51]. Altogether, this suggests that
simultaneous changes in lymphocyte subsets may completely
balance individual atheroprogressive and -protective effects,
without any net effect on atherosclerosis, similarly as observed in
our study.
As macrophages play an important role in the uptake of
modified lipids in atherosclerotic lesions, we examined the effect of
an IkkaAA/AA knock-in on macrophage intracellular lipid accumu-
lation. However, no significant differences were observed in vitro or
in atherosclerotic lesions in vivo (Figure 7), which is similar as
previously observed for Ldlr2/2 mice with a myeloid-specific
deletion of Ikkb [11].
Figure 4. Knock-in of IkkaAA/AA in haematopoietic cells does not
influence apoptosis in atherosclerotic lesions. Analysis of aortic
root lesions of Apoe2/2 mice transplanted with IkkaAA/AAApoe2/2 or
Ikka+/+Apoe2/2 BM and receiving a high-fat diet for 13 weeks. (A)
Quantification of necrotic cores as percentage of plaque area. (B–C)
Quantification of apoptotic cells (Tunel+, B) and apoptotic macrophages
(Tunel+Mac2+, C) as percentage of all plaque cells. Graphs represent the
mean 6 SEM (n= 10–12).
doi:10.1371/journal.pone.0087452.g004
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Furthermore, the IkkaAA/AA knock-in mutation was previously
shown to reduce macrophage apoptosis upon bacterial infection,
which was associated with prolonged LPS-triggered NF-kB p65
activation in BM-derived macrophages [19]. As apoptosis is an
important process in atherogenesis, being atheroprotective in early
stages of disease but associated with plaque necrosis and
atheroprogression in later phases [52], we investigated lesional
apoptosis in IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 BM chimeras.
However, no significant differences were observed in cellular or
macrophage apoptosis, and also necrotic core sizes were compa-
rable (Figure 4). Furthermore, we did not observe a differential
activity of NF-kB p65 upon LPS stimulation of IkkaAA/AAApoe2/2
Figure 5. IkkaAA/AA knock-in in haematopoietic cells does not influence earlier stages of atherogenesis in Apoe2/2mice. Apoe2/2 mice
were transplanted with IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM and received a high-cholesterol diet for 8 weeks before analysis. (A,B) Body weight
(A) and lipid analysis in blood serum (B) (n = 7–9). (C) Cholesterol levels after HPLC-based size fractionation of pooled blood serum samples. (D,E)
Atherosclerotic lesion sizes in the aorta (D) and aortic root (E). Representative pictures of Oil-Red-O+ lipid depositions in aorta and aortic root are
shown. Scale bar = 500 mm. (F) Classification of aortic root lesions according to their severity. Shown is the plaque distribution as percentage of the
total number of lesions examined (n = 22–26). (A,B,D,E) Graphs represent the mean 6 SEM.
doi:10.1371/journal.pone.0087452.g005
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vs Ikka+/+Apoe2/2 BM-derived macrophages in vitro, and even
detected a reduced response in p65 activation upon atherogenic
(i.e. Tnf-a, oxLDL) exposure (Figure 6A). Although these
differential observations between our study and the one from
Lawrence and colleagues [19] are unexpected at first sight, a
major difference between the two studies is the use of Apoe2/2
macrophages in our report. ApoE has been recognized as an
important immunomodulator, which in macrophages promotes
the anti-inflammatory M2 phenotype [53]. It is well-known that
regulatory effects on NF-kB signalling behave cell type-specific,
also in the context of Ikka-mediated NF-kB regulation. For
example, the IkkaAA/AA knock-in mutation did not affect LPS-
induced canonical NF-kB activation in BM-derived DCs [31], and
even induced a small reduction in basal and LPS-induced NF-kB
activation in B-cells [15]. Thus, the dissimilar effects of an IkkaAA/
AA knock-in mutation on LPS-induced NF-kB p65 activity in
macrophages in our study compared to the one from Lawrence et
al. [19] could be due to differential macrophage phenotypes
induced by Apoe-deficiency or even by different culturing
conditions. Furthermore, NF-kB regulatory mechanisms are often
stimulus-dependent, as also exemplified by the observation that an
IkkaAA/AA knock-in did not affect Tnf-a-mediated NF-kB activa-
tion in fibroblasts or mammary epithelial cells [22]. This could
additionally explain why in our study no prolonged p65 activity
could be observed in Tnf-a- or oxLDL-stimulated IkkaAA/AA
macrophages in vitro.
Although the effect of Ikka on NF-kB stability in macrophages
was only described for the isoforms p65 and c-Rel [19], also p50
activity has been reported in atherosclerotic lesions [54–56]. Even
more, it has been suggested that p50-p50 homodimers represent
the main NF-kB activity during inflammation resolution, at least
in a rat carrageenin-induced pleurisy model [8], which could
correspond to the higher inflammatory phenotype of atheroscle-
rotic lesions in Ldlr2/2 mice with a haematopoietic p50 deficiency
[57]. Although beyond the scope of this study, it would be
interesting to perform a detailed characterization of canonical NF-
Figure 6. IkkaAA/AA knock-in does not enhance or prolong NF-kB p65 activity, or majorly influence cytokine expression in Apoe2/2
macrophages in vitro. (A) BM-derived macrophages from IkkaAA/AAApoe2/2 and Ikka+/+Apoe2/2 mice were stimulated in vitro with 10 ng/ml Tnf-a,
50 mg/ml of mildly oxidized LDL or 100 ng/ml LPS for the indicated time. Activation of p65 was quantified in nuclear extracts using a TransAm p65
assay. Graphs represent the mean 6 SEM (n= 2); 2-way ANOVA with Bonferroni post-test, ***P,0.001. (B) BM-derived macrophages from IkkaAA/
AAApoe2/2 and Ikka+/+Apoe2/2 mice were stimulated in vitro for 24 h with 10 ng/ml Tnf-a or 50 mg/ml heavily oxidized LDL. Cytokine concentrations
in the supernatants are displayed for Tnf-a, Il-6 and Mcp1. Graphs represent mean6 SEM (n= 9 from 3 independent experiments); 2-way ANOVA with
Bonferroni post-test, ***P,0.001. (C) Concentrations of Tnf-a, Mcp1 and Il-6 in serum of Apoe2/2 mice transplanted with IkkaAA/AAApoe2/2 or Ikka+/
+Apoe2/2 BM and receiving a high-fat diet for 8 weeks. Graphs represent the mean 6 SEM (n= 7–9).
doi:10.1371/journal.pone.0087452.g006
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Figure 7. IkkaAA/AA knock-in does not influence macrophage lipid uptake. (A) Flow cytometric analysis of Dil-oxLDL uptake by BM-derived
macrophages. Cells were incubated without or with Dil-oxLDL (1 mg/ml or 10 mg/ml) for 3 h or 24 h, as indicated. To test for actin-dependent uptake,
additional controls were simultaneously treated with cytochalasin D (cytD), as indicated. Representative flow cytometric histograms are shown.
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kB isoform activity in different stages of atherosclerosis and
investigate a potential regulation by the IKKa kinase under these
specific atherosclerotic conditions in vivo. Simultaneously, the
activity of non-canonical NF-kB isoforms in the course of
atherogenesis could be readdressed. Although a single study
reported the absence of p52 and RelB activity in isolated human
atherosclerotic plaque cells [55], a recent report identified a
significant upregulation of IKKa and p52 during human
monocyte-macrophage differentiation in vitro. This enables p52-
mediated transcriptional repression under basal conditions,
possibly preventing macrophage hyperactivation, but facilitates
enhanced RelB-52 activity upon inflammation-induced RelB
expression [58].
Our study did not reveal significant differences in inflammatory
protein levels in the supernatants of Tnfa- or oxLDL-stimulated
IkkaAA/AAApoe2/2 vs Ikka+/+Apoe2/2 BM-derived macrophages,
with the exception of Il-12 which showed a significant increase in
oxLDL-stimulated macrophages upon IkkaAA/AA knock-in
(Figure 6B, Figure S6). Furthermore, we could not detect
significant differences in macrophage-related inflammatory cyto-
kine and chemokine levels in the serum of atherosclerotic IkkaAA/
AAApoe2/2 vs Ikka+/+Apoe2/2 BM chimeras (Figure 6C). Thus,
despite the diverse roles of the Ikka kinase in modulating gene
expression in an NF-kB-dependent or -independent manner
[4,14], these functions do not seem strong enough in the context
of atherogenesis to produce a major effect on systemic protein
expression upon IkkaAA/AA knock-in.
Furthermore, it is important to remember that the identification
of novel IKKa substrates continuously extends the molecular
pathways and biological processes affected by this kinase [4,14].
Also, atherosclerosis is influenced by many leukocyte subsets [1,2].
Therefore, it is conceivable that our overall zero effect of the BM-
specific IkkaAA mutation on atherosclerosis is at least partially the
result of counterbalanced effects on different biological processes
in macrophages or even different leukocyte subsets. For example,
it would be interesting to study the effect of a DC- or Treg-specific
IkkaAA/AA mutation on atherogenesis. Also, both IKKa and IKKb
were shown to be important in neutrophil chemotaxis to HMGB1,
a nuclear protein released by necrotic cells, but the functions of the
IKKa kinase activity in neutrophil responses and molecular
signalling in the context of inflammation and atherosclerosis have
not yet been investigated. In addition, the role of IKKa in vascular
cells remains to be investigated in more detail.
In conclusion, our data identify an important and previously
unrecognized role for the haematopoietic Ikka kinase activity in B-
and T-cell homeostasis in conditions of atherosclerosis. However,
the BM-specific IkkaAA knock-in in atherosclerotic mice did not
affect the size or phenotype of atherosclerotic lesions. This
indicates that the diverse functions of Ikka in haematopoietic
cells may counterbalance each other or may not be strong enough
to influence atherogenesis, and reveals that targeting haematopoi-
etic Ikka kinase activity alone may not represent a suitable
therapeutic approach. Although the overall zero effect on
atherosclerosis is surprising at first sight, it has been observed
before that deficiency of proteins with an important role in
inflammatory signalling and biological processes does not induce
any changes in the size or composition of atherosclerotic lesions, as
for example described for BM-deficiency of Cd40 ligand [59,60] or
Traf6 [61]. Also, atherosclerosis was not affected in Ldlr2/2 mice
with a BM p16INK4a-deficiency [62], despite the fact that p16INK4a
is a regulator of macrophage activation and polarization and
p16INK4a-deficiency reduces LPS-induced NF-kB activation in BM-
derived macrophages [63]. Clearly, it would be interesting to
address in the future the role of the IKKa kinase in atherosclerosis
in different leukocyte subsets individually and in vascular cells.
Supporting Information
Figure S1 Effect of a bone marrow-specific IkkaAA/AA
knock-in on B- and T-cell populations in bone marrow
and secondary lymphoid organs. Shown is flow cytometric
analysis of bone marrow, spleen and lymph nodes from Apoe2/2
mice transplanted with IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM
and receiving a high-cholesterol diet for 13 weeks. (A) Cd19+ B-cell
population as percentage of Cd45+ leukocytes. (B–C) Cd19+ B-cell
and Cd3+ T-cell populations as percentage of Cd45+ leukocytes,
and Cd4+ and Cd8a+ T-cell subsets as percentage of Cd3+ T-cells
in lymph nodes (B) and spleen (C). All graphs represent the mean
6 SEM (n=18–19), 2-tailed t-test, ***P,0.001.
(DOCX)
Figure S2 Effect of a bone marrow-specific IkkaAA/AA
knock-in on Treg, naive and effector memory T-cells.
Shown are representative dot plots of the FACS-based gating
strategy of T-cell subpopulations within splenic leukocytes from
Ikka+/+Apoe2/2 and IkkaAA/AAApoe2/2 BM chimeras after 13 weeks
of high-cholesterol diet. (A) Within the Cd3+ T-cell population,
Treg cells were defined as Cd4
+Cd25+Foxp3+ cells. (B) Within the
Cd3+ T-cell population, naive T-cells were defined as
Cd44lowCd62Lhigh T-cells and effector memory T-cells as
Cd44highCd62Llow T-cells. (A,B) Percentages indicate the % from
the Cd3+ T-cell population.
(DOCX)
Figure S3 Effect of a bone marrow-specific IkkaAA/AA
knock-in on central memory T-cells. Shown is flow
cytometric analysis of Cd44highCd62Lhigh central memory T-cells
in spleen and lymph nodes from Apoe2/2 mice transplanted with
IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM and receiving a high-
cholesterol diet for 13 weeks. Data are represented as percentage
of Cd3+ T-cells (left) and as percentage of Cd45+ leukocytes (right).
Graphs represent the mean 6 SEM (n= 18–19), 2-tailed t-test,
*P,0.05, **P,0.01, ***P,0.001.
(DOCX)
Figure S4 Effect of a bone marrow-specific IkkaAA/AA
knock-in on B- and T-cell populations in a non-
atherosclerotic context. Shown is flow cytometric analysis of
spleen and lymph nodes from C57BL/6 mice transplanted with
IkkaAA/AA or Ikka+/+ BM. Dead cells were excluded using Sytox
Blue. (A) B220+ B-cell population as percentage of leukocytes, and
the total number of B-cells in spleen and lymph nodes. (B) Cd4+
and Cd8a+ T-cell subsets as percentage of leukocytes, and as
percentage of Cd3+ T-cells. (C) Total number of Cd3+Cd4+ and
Graphs represent the mean 6 SEM (n= 3); 2-way ANOVA with Bonferroni post-test. (B–D) Intracellular lipid depositions in aortic root lesions were
stained with Nile Red and co-stained with Mac2 in order to quantify lipid-laden macrophages. (B) Nile Red staining was quantified relative to the
plaque area (left graph), and Nile Red+ cells were quantified as percentage of total plaque cells (right graph). (C) Lipid uptake by macrophages was
quantified as Nile Red+Mac2+ area as % of Mac2+ area (left graph), and as Nile Red+Mac2+ cells as % of Mac2+-cells. (D) Shown are representative
pictures from Nile Red staining (red fluorescence; left image). The middle and right image demonstrate Image J analyses. Displayed are the plaque
area (thin red line), macrophage area (green), plaque cell nuclei (blue), Nile Red+ area (yellow) and Mac2+ Nile Red+ area (white, lipid deposits in
macrophages). Graphs represent the mean 6 SEM (n= 5–6).
doi:10.1371/journal.pone.0087452.g007
Ikka Kinase in Haematopoiesis and Atherosclerosis
PLOS ONE | www.plosone.org 13 February 2014 | Volume 9 | Issue 2 | e87452
Cd3+Cd8a+ T-cell subsets, and total leukocyte number in spleen
and lymph nodes. All graphs represent the mean 6 SEM (n=5);
2-tailed t-test; *P,0.05, **P,0.01, ***P,0.001.
(DOCX)
Figure S5 Effect of a bone marrow-specific IkkaAA/AA
knock-in on Treg-cells in a non-atherosclerotic context.
Shown is flow cytometric analysis of Treg-cells in lymph nodes
from C57BL/6 mice transplanted with IkkaAA/AA or Ikka+/+ BM.
Dead cells were excluded using Sytox Blue. (A) Cd4+Foxp3+ Treg-
cells as percentage of leukocytes (left), and Cd4+Cd25+Foxp3+
Treg-cells as percentage of Cd4
+ T-cells (right). (B) Total numbers
of Cd4+Foxp3+ Treg-cells (left), and total numbers of
Cd4+Cd25+Foxp3+ Treg-cells. Graphs represent the mean 6
SEM (n= 5), 2-tailed t-test, *P,0.05, **P,0.01, ***P,0.001.
(DOCX)
Figure S6 Effect of IkkaAA/AA knock-in on cytokine
secretion from BM-derived macrophages. Shown are
cytokine concentrations of Il-10 and Il-12p70 in the supernatants
of IkkaAA/AAApoe2/2 or Ikka+/+Apoe2/2 BM-derived macrophages,
unstimulated or after stimulation for 24 h with 10 ng/ml Tnf-a or
50 mg/ml oxLDL, as indicated. Graphs represent mean 6 SEM
(n= 9 from 3 independent experiments); 2-way ANOVA with
Bonferroni post-test, *P,0.05, **P,0.01.
(DOCX)
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